CEBPG Exhibits Allele-Specific Expression in Human Bronchial Epithelial Cells

Area of Science:

• Genetics
• Molecular Biology
• Cancer Research

Background:

• Inter-individual variation in CCAAT/enhancer binding protein gamma (CEBPG) transcript expression in normal human bronchial epithelial cells (NBEC) is linked to lung cancer predisposition.
• Genetic factors are suspected to contribute to this variation in CEBPG expression.

Purpose of the Study:

• To investigate if cis-acting genetic variation in CEBPG explains inter-individual differences in its transcript expression.
• To determine the role of specific genetic variants, like rs2772, in regulating CEBPG expression.

Main Methods:

• Measurement of allele-specific expression (ASE) of CEBPG in NBEC samples.
• Analysis of the relationship between genetic variants (e.g., CEBPG rs2772) and CEBPG transcript levels.
• Statistical analysis to assess the significance of observed variations.

Main Results:

• A significant 2.9-fold higher cell cycle-specific variation in ASE of the CEBPG rs2772 A allele compared to the C allele was observed (P < 0.001).
• In 20% of NBEC samples, the rs2772 A allele showed an average 2.10-fold greater expression than the C allele.
• Evidence suggests a trans-effect influencing CEBPG regulation downstream of RNA polymerase II transcription.

Conclusions:

• Cis-acting genetic variation in CEBPG contributes to inter-individual differences in its transcript expression in NBEC.
• These expression variations are associated with differences in lung cancer risk.
• Genetic variants like rs2772 play a role in the regulation of CEBPG expression.